Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05864222 · ClinicalTrials.gov registry record · NA
Aromatherapy and Happiness
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05864222: Completed NA study, sponsored by NYU Langone Health.
NCT05864222 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05864222, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the impact that aromatherapy has on nurses' self-perception of happiness and workplace satisfaction. After completing the informed consent process, participants will complete a demographic survey, the Oxford Happiness Questionnaire (OHQ), and the Nursing Job Satisfaction Survey (NJSS). Aromatherapy (AT), via AT stickers on employee badges, will begin after baseline measurements. OHQ and NJSS will be measured again at 3 months and 6 months of AT. After completion of the intervention, participants will also complete a qualitative survey addressing overall self-reported impact of AT. Analysis will occur after final data is collected.
Primary Outcome
23-item assessment of job satisfaction among nurses. Items are ranked on a scale from 0 (strongly disagree) to 4 (strongly agree). The total score ranges from 0 to 92; higher scores indicate greater satisfaction.
Interventions
- OTHER Aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2024-02-24 |
| Phase | NA |
What the finished NCT05864222 record still lists
NCT05864222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Aromatherapy is the first listed.
NCT05864222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05864222 about?
NCT05864222 is a clinical study titled "Aromatherapy and Happiness". The purpose of this study is to explore the impact that aromatherapy has on nurses' self-perception of happiness and workplace satisfaction. After completing the informed consent process, participants will complete a demographic survey, the Oxford Happiness Questionnaire (OHQ), and the Nursing Job S...
What is the current status of trial NCT05864222?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-05-09. Estimated completion is 2024-02-24.
What interventions are being tested in trial NCT05864222?
The interventions under investigation include: Aromatherapy (OTHER).
Who is sponsoring clinical trial NCT05864222?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05864222's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI